{"id":297097,"date":"2023-11-15T20:26:44","date_gmt":"2023-11-16T01:26:44","guid":{"rendered":"https:\/\/platohealth.ai\/comparing-sales-of-cd20xcd3-bispecifics-for-lymphoma\/"},"modified":"2023-11-16T09:30:42","modified_gmt":"2023-11-16T14:30:42","slug":"comparing-sales-of-cd20xcd3-bispecifics-for-lymphoma","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/comparing-sales-of-cd20xcd3-bispecifics-for-lymphoma\/","title":{"rendered":"Comparing\u00a0sales of CD20xCD3 bispecifics for lymphoma","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
DATA GRAPHICS | Data Byte<\/p>\n
By <\/span>Gunjan Ohri, Data Content Analyst<\/span><\/span>\n<\/p>\n November 16, 2023 1:26 AM UTC<\/p>\n<\/div>\n<\/div>\n<\/div>\n In its second quarter on the market, sales of Genmab and AbbVie\u2019s subcutaneous CD20xCD3 bispecific, Epkinly, grew nearly fourfold, surpassing sales of competing intravenous CD20xCD3 bispecifics from Roche<\/a> and Biogen.<\/p>\n FDA approved Epkinly epcoritamab, developed by partners Genmab A\/S<\/a> (CSE:GMAB; NASDAQ:GMAB) and AbbVie Inc.<\/a> (NYSE:ABBV), on May 19 to treat diffuse large B-cell lymphoma (DLBCL) after two or more lines of treatment. The approval was the first of two this year for a CD20xCD3 bispecific in the indication, followed by Columvi glofitamab from Roche (SIX:ROG; OTCQX:RHHBY) on June <\/span>15…<\/p>\n DATA GRAPHICS | Data Byte Epkinly sales take off in its second quarter on the market By Gunjan Ohri, Data Content Analyst November 16, 2023 1:26 AM UTC In its second quarter on the market, sales of Genmab and AbbVie\u2019s subcutaneous CD20xCD3 bispecific, Epkinly, grew nearly fourfold, surpassing sales of competing intravenous CD20xCD3 bispecifics from Roche […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":297101,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[50],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/297097"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=297097"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/297097\/revisions"}],"predecessor-version":[{"id":297100,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/297097\/revisions\/297100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/297101"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=297097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=297097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=297097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/span><\/div>\n
\n